Monitor for release of full 8-K details or follow-up filings; absence of financial data prevents assessment of materiality. Given the small market cap ($37M), any leadership change could disproportionately affect investor sentiment.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 12 $0.4210entry
- T+1 · 8mo ago −6.41%α −5.82% · $0.3940
- T+5 · 8mo ago −20.19%α −19.21% · $0.3360
- T+20 · 7mo ago −40.86%α −42.83% · $0.2490
- T+60 · 5mo ago +84.56%α +73.86% · $0.7770
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Analysis based on filing metadata only, document content was unavailable. The filing reports a departure or appointment of an officer or director (Item 5.02) and includes financial statements or exhibits (Item 9.01), but no specific details or financial impact can be determined without the full document.
Key Facts
- Filing is an 8-K report for Outlook Therapeutics, Inc. (OTLK)
- Items disclosed: 5.02 (Departure/Appointment of Directors or Officers) and 9.01 (Financial Statements and Exhibits)
- No document content available to assess specifics of executive change or nature of exhibits
Financial Impact
Not specified
Risk Factors
- Material executive departure or governance issue may be undisclosed due to missing content
- Potential delay in financial reporting or material agreement not captured
Market Snapshot
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
37 reports on OTLK
13 of 23 bullish or bearish reports moved the stock their way by T+5. Best: +306.25% at T+20 after the May 26, 2026 report. 18 of 23 went positive at some point.
Filters
- Oct 13, 20264w ago SC 13G Neutral 4/10 Entry $0.5638 to $0.5200 Now $0.3960 −29.76% ▼ −7.77% −6.62% vs SPY
- Oct 6, 20265w ago Press Release Neutral 3/10 Entry $0.5720 to $0.5638 Now $0.3960 −30.77% ▼ −1.43% −1.29% vs SPY
- Sep 18, 20268w ago 8-K Neutral 3/10 Entry $0.6863 to $0.6211 Now $0.3960 −42.30% ▼ −9.50% −8.48% vs SPY
- Aug 14, 202613w ago 8-K Bearish 6/10 Entry $0.7564 to $0.6472 Now $0.3960 +47.65% ▲ +14.44% +13.07% vs SPY
- Aug 14, 202613w ago 424B5 Bearish 7/10 Entry $0.7564 to $0.6472 Now $0.3960 +47.65% ▲ +14.44% +13.07% vs SPY
- Aug 14, 202613w ago 8-K Bearish 6/10 No price data
- Aug 14, 202613w ago Press Release Mixed 7/10 Entry $0.7564 to $0.6472 Now $0.3960 −47.65% ▼ −14.44% −13.07% vs SPY
- Aug 12, 202613w ago Press Release Bearish 7/10 Entry $0.8888 to $0.6763 Now $0.3960 +55.45% ▲ +23.91% +21.94% vs SPY
- Aug 12, 202613w ago 8-K Bearish 7/10 Entry $0.8888 to $0.6763 Now $0.3960 +55.45% ▲ +23.91% +21.94% vs SPY
- Jul 24, 202616w ago 8-K Bullish 8/10 Entry $1.07 to $0.9766 Now $0.3960 −62.82% ▼ −8.30% −9.37% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers